Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab
Status:
Recruiting
Trial end date:
2023-03-10
Target enrollment:
Participant gender:
Summary
This study will be conducted to compare the pharmacokinetic (PK) exposure after a single SC
dose of anifrolumab administered using an AI with the PK exposure after a single subcutaneous
(SC) dose of anifrolumab administered using APFS in healthy male and female volunteers.